The New Age of Regenerative Medicine

The New Age of Regenerative Medicine

Why Stem Cell Therapy?

RELEASE DATE
02-Sep-2015
REGION
Global
Deliverable Type
Market Research
Research Code: 9AB9-00-3D-00-00
SKU: LS00078-GL-MR_16919
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
LS00078-GL-MR_16919

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the ageing population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

Key Questions This Study Will Answer

Regenerative Medicine Industry—Where We Stand Today

Regenerative Medicine Industry—Where We Stand Today (continued)

Regenerative Medicine Industry—Key Stakeholders

Definition—Regenerative Medicine

Regenerative Medicine—Market Segmentation

Why is Regenerative Medicine Important to the Future of Healthcare?

Market Size and Growth—Regenerative Medicine

Geographical Overview for Regenerative Medicine Companies

Total Regenerative Medicine Industry

Definitions—Cell Therapy and Stem Cell Therapy

Cell Therapy—Commercially Available Products by Therapy

Overview of Competing Products—By Development and Key Participants

Commercially Available Primary Cell Therapy and Allograft Products

Commercially Available Primary Cell Therapy and Allograft Products (continued)

Cellular Dynamics International (CDI), Madison, Wisconsin

Orthofix International, Lewisville, Texas

Capricor Therapeutics, Beverly Hills, California

Big Pharmaceuticals and Regenerative Medicine

Market Drivers and Restraints for Stem Cell Manufacturing

Stem Cell Consumer Information—The United States

Stem Cell Consumer Information—Global

Future Trends

Market Opportunities

Global Partnerships and Deals for Regenerative Medicine

Key Global Partnerships and Deals for Regenerative Medicine

Regenerative Medicine Market—Funding Scenario

Regenerative Medicine—Asia-Pacific Market Overview

Regenerative Medicine—Leading APAC Countries

Regenerative Medicine—Leading APAC Countries(continued)

Regenerative Medicine—Lifecycle for Leading APAC Countries

Regenerative Medicine—South Korea

Regenerative Medicine—China

Regenerative Medicine—Japan

Regenerative Medicine—Singapore

Regenerative Medicine—Key Market Access Barriers

Successful Stem Cell Therapy Company—MEDIPOST Co., Ltd.

Successful Stem Cell Therapy Company—Mesoblast Ltd.

The Last Word

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases such as cancer, heart disease, and neuro-muscular ailments among the ageing population. This research study provides an overview of the regenerative medicine industry and an insight on successful stem cell therapy treatments. It also analyses marketed products, stem cell manufacturing and funding, and the collaborative partnerships in the regenerative medicine industry.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Jane Andrews, Ph.D.
WIP Number 9AB9-00-3D-00-00
Is Prebook No